Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 2
Reauthorize Vector-Borne Disease Centers and National Strategy
Reauthorizes and modestly expands the national strategy and regional centers of excellence in vector-borne disease program under Section 317U of the Public Health Service Act (PHSA), extending funding authorization from fiscal years 2021–2025 to 2026–2030, adding an explicit capacity-building objective to the centers of excellence, and replacing a specific reference to the now-defunct Tick-Borne Disease Working Group with broader consultee language.
- Population Scope Medium Directly affects state and local public health agencies, researchers at regional centers of excellence, and populations in vector-borne disease-endemic areas — a meaningful but sub-national share of the U.S. population.
- Budgetary Magnitude Medium Extends authorization to appropriate funds for fiscal years 2026–2030 but specifies no dollar amount, leaving appropriations to future congressional action.
- Legal / Regulatory Depth Medium Extends an existing statutory authorization window and adds a capacity-building objective, adjusting the procedural scope of an ongoing program rather than creating a new substantive mandate or enforceable right.
- Degree of Discretion Granted Medium Replacing mandatory consultation with the Tick-Borne Disease Working Group with discretionary consultation of 'appropriate individuals' broadens agency latitude in how it solicits input for the national strategy.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are created; the amendments extend and modestly expand an administrative grant program.
- Temporal Commitment Low Authorization expires at the end of fiscal year 2030, self-terminating within the 10-year threshold unless Congress acts to extend it again.
No signal yet
Core Policy Mechanism Top 2
Reauthorize Health Department Vector-Borne Disease Support
Reauthorizes the enhanced support program to assist state and local health departments in addressing vector-borne diseases under Section 2822 of the PHSA, extending the funding authorization period from fiscal years 2021–2025 to 2026–2030.
- Population Scope Medium Directly supports state and local health departments nationwide, indirectly benefiting populations in vector-borne disease-affected regions — a significant but sub-national share of the U.S. population.
- Budgetary Magnitude Medium Extends authorization to appropriate funds for fiscal years 2026–2030 but specifies no dollar amount, leaving actual appropriations to future congressional action.
- Legal / Regulatory Depth Low Solely updates a single date range in an existing authorization clause, making no substantive change to program structure, mandates, or legal obligations.
- Degree of Discretion Granted Medium Continues the existing framework under which the Department of Health and Human Services (HHS) retains discretion in allocating enhanced support grants to health departments, with no change to that latitude.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance requirements are introduced; the provision simply extends an existing grant support program.
- Temporal Commitment Low Authorization expires at the end of fiscal year 2030, self-terminating within the 10-year threshold unless Congress affirmatively extends it.
No signal yet
No possible riders have been surfaced for this bill.
Summary
This bill reauthorizes the Kay Hagan Tick Act by extending federal programs addressing vector-borne diseases through fiscal years 2026–2030. It renews both the national strategy and regional centers of excellence in vector-borne disease under the Public Health Service Act (PHSA) and the enhanced support program for state and local health departments, while also expanding the scope of the centers-of-excellence program to explicitly include capacity building for identifying, reporting, preventing, and responding to vector-borne diseases, and updating consultation language.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Jul 10, 2025
|
Jul 10, 2025 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 2
Reauthorize Vector-Borne Disease Centers and National Strategy
Reauthorizes and modestly expands the national strategy and regional centers of excellence in vector-borne disease program under Section 317U of the Public Health Service Act (PHSA), extending funding authorization from fiscal years 2021–2025 to 2026–2030, adding an explicit capacity-building objective to the centers of excellence, and replacing a specific reference to the now-defunct Tick-Borne Disease Working Group with broader consultee language.
- Population Scope Medium Directly affects state and local public health agencies, researchers at regional centers of excellence, and populations in vector-borne disease-endemic areas — a meaningful but sub-national share of the U.S. population.
- Budgetary Magnitude Medium Extends authorization to appropriate funds for fiscal years 2026–2030 but specifies no dollar amount, leaving appropriations to future congressional action.
- Legal / Regulatory Depth Medium Extends an existing statutory authorization window and adds a capacity-building objective, adjusting the procedural scope of an ongoing program rather than creating a new substantive mandate or enforceable right.
- Degree of Discretion Granted Medium Replacing mandatory consultation with the Tick-Borne Disease Working Group with discretionary consultation of 'appropriate individuals' broadens agency latitude in how it solicits input for the national strategy.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance obligations are created; the amendments extend and modestly expand an administrative grant program.
- Temporal Commitment Low Authorization expires at the end of fiscal year 2030, self-terminating within the 10-year threshold unless Congress acts to extend it again.
No signal yet
Core Policy Mechanism
Reauthorize Vector-Borne Disease Centers and National Strategy
Core Policy Mechanism Top 2
Reauthorize Health Department Vector-Borne Disease Support
Reauthorizes the enhanced support program to assist state and local health departments in addressing vector-borne diseases under Section 2822 of the PHSA, extending the funding authorization period from fiscal years 2021–2025 to 2026–2030.
- Population Scope Medium Directly supports state and local health departments nationwide, indirectly benefiting populations in vector-borne disease-affected regions — a significant but sub-national share of the U.S. population.
- Budgetary Magnitude Medium Extends authorization to appropriate funds for fiscal years 2026–2030 but specifies no dollar amount, leaving actual appropriations to future congressional action.
- Legal / Regulatory Depth Low Solely updates a single date range in an existing authorization clause, making no substantive change to program structure, mandates, or legal obligations.
- Degree of Discretion Granted Medium Continues the existing framework under which the Department of Health and Human Services (HHS) retains discretion in allocating enhanced support grants to health departments, with no change to that latitude.
- Implementation & Enforcement Burden Low No new enforcement mechanisms, penalties, or compliance requirements are introduced; the provision simply extends an existing grant support program.
- Temporal Commitment Low Authorization expires at the end of fiscal year 2030, self-terminating within the 10-year threshold unless Congress affirmatively extends it.
No signal yet
Core Policy Mechanism
Reauthorize Health Department Vector-Borne Disease Support
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: